This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Annika Kyssä - Innovator in Pharmaceutical Formulations
Introduction
Annika Kyssä is a talented inventor based in Södertälje, Sweden. She is currently associated with AstraZeneca AB, where she contributes to the development of innovative pharmaceutical solutions. Although she has not yet been granted any patents, her work in the field of solid pharmaceutical formulations is noteworthy.
Latest Patent Applications
Annika Kyssä's recent patent application focuses on "Solid Pharmaceutical Formulations of 6-(2-Chloro-6-Methylpyridin-4-Yl)-5-(4-Fluorophenyl)-1,2,4-Triazine-3-Amine." This application describes solid formulations that include a polymeric stabilizer, such as polyvinylpyrrolidone, an ionic surfactant like sodium docusate, and a non-ionic surfactant such as poloxamer. These formulations aim to enhance the stability and efficacy of the pharmaceutical compound AZD4635.
Conclusion
Annika Kyssä is making significant strides in the pharmaceutical industry through her innovative research and applications. Her contributions, although not yet reflected in granted patents, hold promise for future advancements in solid pharmaceutical formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile